Jefferies Assumes Carisma Therapeutics Inc (CARM) at Buy, 'Charismatic Cell Therapy Harnesses the Properties of Macrophages'
Tweet Send to a Friend
(Updated - May 31, 2023 7:40 AM EDT)
Jefferies analyst Kambiz Yazdi assumes coverage on Carisma Therapeutics Inc (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst Kambiz Yazdi assumes coverage on Carisma Therapeutics Inc (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
